Literature DB >> 1566281

Effect of avarol and avarone on in vitro-induced microsomal lipid peroxidation.

M A Belisario1, M Maturo, R Pecce, S De Rosa, G R Villani.   

Abstract

Lipid peroxidation was employed as an experimental model to study the antioxidant properties of avarol, a sesquiterpenoid hydroquinone and of its quinone, avarone. In the NADPH- or ascorbate-linked lipid peroxidation, avarol and avarone were shown to be more effective as inhibitors than in the t-BuOOH-dependent peroxidative process. However, in all three systems employed avarol was a more powerful inhibitor than avarone. The chemical structure of avarol, having an easily donatable hydrogen atom and its kinetics of inhibition suggested that the hydroquinone acted mainly as a radical scavenger. Conversely avarone appeared to interfere mainly with the initiation phase of lipid peroxidation. However, avarol and the semiquinone intermediate may contribute to the inhibitory action of the quinone. In fact avarone reduction to avarol has been shown to occur in the presence of reducing agents such as ascorbate or Fe(II) and to be catalyzed by NADPH-supplemented microsomes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566281     DOI: 10.1016/0300-483x(92)90114-t

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  2 in total

1.  Quantitative assessment of natural toxicity in sponges: toxicity bioassay versus compound quantification.

Authors:  Ruth Martí; Angelo Fontana; María-J Uriz; Guido Cimino
Journal:  J Chem Ecol       Date:  2003-06       Impact factor: 2.626

2.  Investigating the Antiparasitic Potential of the Marine Sesquiterpene Avarone, Its Reduced form Avarol, and the Novel Semisynthetic Thiazinoquinone Analogue Thiazoavarone.

Authors:  Concetta Imperatore; Roberto Gimmelli; Marco Persico; Marcello Casertano; Alessandra Guidi; Fulvio Saccoccia; Giovina Ruberti; Paolo Luciano; Anna Aiello; Silvia Parapini; Sibel Avunduk; Nicoletta Basilico; Caterina Fattorusso; Marialuisa Menna
Journal:  Mar Drugs       Date:  2020-02-14       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.